5-[4-[(2-chloropyrrolo[2,1-f][1,2,4]triazin-4-yl)amino]imidazol-1-yl]-N-cyclopentyl-2,3-dimethoxybenzamide
C23H24ClN7O3 — CID 142498603
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-[(2-chloropyrrolo[2,1-f][1,2,4]triazin-4-yl)amino]imidazol-1-yl]-N-cyclopentyl-2,3-dimethoxybenzamide
5-[4-[(2-chloropyrrolo[2,1-f][1,2,4]triazin-4-yl)amino]imidazol-1-yl]-N-cyclopentyl-2,3-dimethoxybenzamide (PubChem CID 142498603) has the molecular formula C23H24ClN7O3 and a molecular weight of 481.94 g/mol. Its IUPAC name is 5-[4-[(2-chloropyrrolo[2,1-f][1,2,4]triazin-4-yl)amino]imidazol-1-yl]-N-cyclopentyl-2,3-dimethoxybenzamide.
Molecular Properties
| Compound Name | 5-[4-[(2-chloropyrrolo[2,1-f][1,2,4]triazin-4-yl)amino]imidazol-1-yl]-N-cyclopentyl-2,3-dimethoxybenzamide |
|---|---|
| PubChem CID | 142498603 |
| Molecular Formula | C23H24ClN7O3 |
| Molecular Weight | 481.94 g/mol |
| Exact Mass | 481.16 |
| IUPAC Name | 5-[4-[(2-chloropyrrolo[2,1-f][1,2,4]triazin-4-yl)amino]imidazol-1-yl]-N-cyclopentyl-2,3-dimethoxybenzamide |
| SMILES | COc1cc(-n2cnc(Nc3nc(Cl)nn4cccc34)c2)cc(C(=O)NC2CCCC2)c1OC |
| InChI | InChI=1S/C23H24ClN7O3/c1-33-18-11-15(10-16(20(18)34-2)22(32)26-14-6-3-4-7-14)30-12-19(25-13-30)27-21-17-8-5-9-31(17)29-23(24)28-21/h5,8-14H,3-4,6-7H2,1-2H3,(H,26,32)(H,27,28,29) |
| InChIKey | GVKIPBRTOIPBDT-UHFFFAOYSA-N |
| XLogP | 4.00 |
| TPSA | 107.60 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 481.94 |
| LogP ≤ 5 | 4.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142498603 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.